| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACT II: treatment of anal cancer comes full circle
|
Willett, Christopher G
|
|
2013
|
14 |
6 |
p. 443-445
3 p.
|
artikel
|
| 2 |
ALK-targeted therapy for poor-prognosis childhood cancers
|
Moreno, Lucas
|
|
2013
|
14 |
6 |
p. 439-440
2 p.
|
artikel
|
| 3 |
Arm lymphoedema after breast cancer
|
Mortimer, Peter
|
|
2013
|
14 |
6 |
p. 442-443
2 p.
|
artikel
|
| 4 |
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
|
Motzer, Robert J
|
|
2013
|
14 |
6 |
p. 552-562
11 p.
|
artikel
|
| 5 |
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
|
Lordick, Florian
|
|
2013
|
14 |
6 |
p. 490-499
10 p.
|
artikel
|
| 6 |
Cetuximab for liver metastases from colorectal cancer
|
Baker, Holly
|
|
2013
|
14 |
6 |
p. e204-
1 p.
|
artikel
|
| 7 |
Chocolate: delicious beauty or harmful beast?
|
Stebbing, Justin
|
|
2013
|
14 |
6 |
p. 457-458
2 p.
|
artikel
|
| 8 |
CHOP intensification: not yet state of the art
|
Pfreundschuh, Michael
|
|
2013
|
14 |
6 |
p. 445-447
3 p.
|
artikel
|
| 9 |
Cuts to US Medicare disrupt chemotherapy services
|
Furlow, Bryant
|
|
2013
|
14 |
6 |
p. 456-
1 p.
|
artikel
|
| 10 |
Cytokine patterns in patients with cancer: a systematic review
|
Lippitz, Bodo E
|
|
2013
|
14 |
6 |
p. e218-e228
nvt p.
|
artikel
|
| 11 |
Diluted chemotherapy drugs affect 1200 patients in Canada
|
Wong, Jennifer
|
|
2013
|
14 |
6 |
p. e203-
1 p.
|
artikel
|
| 12 |
Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial
|
Delarue, Richard
|
|
2013
|
14 |
6 |
p. 525-533
9 p.
|
artikel
|
| 13 |
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
|
Waddell, Tom
|
|
2013
|
14 |
6 |
p. 481-489
9 p.
|
artikel
|
| 14 |
Gene mutations linked to oesophageal adenocarcinoma
|
Burki, Talha Khan
|
|
2013
|
14 |
6 |
p. e202-
1 p.
|
artikel
|
| 15 |
Has the time come for metronomics in low-income and middle-income countries?
|
André, Nicolas
|
|
2013
|
14 |
6 |
p. e239-e248
nvt p.
|
artikel
|
| 16 |
HeLa
|
Ranscombe, Peter
|
|
2013
|
14 |
6 |
p. 459-
1 p.
|
artikel
|
| 17 |
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
|
DiSipio, Tracey
|
|
2013
|
14 |
6 |
p. 500-515
16 p.
|
artikel
|
| 18 |
Is India ready to lead the battle for fair access to medicines?
|
The Lancet Oncology,
|
|
2013
|
14 |
6 |
p. 437-
1 p.
|
artikel
|
| 19 |
Love Is All You Need
|
Cagney, Hannah
|
|
2013
|
14 |
6 |
p. 460-
1 p.
|
artikel
|
| 20 |
Mesothelioma: closer to the target?
|
Pass, Harvey I
|
|
2013
|
14 |
6 |
p. 448-449
2 p.
|
artikel
|
| 21 |
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
|
Castelo-Branco, Pedro
|
|
2013
|
14 |
6 |
p. 534-542
9 p.
|
artikel
|
| 22 |
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial
|
James, Roger D
|
|
2013
|
14 |
6 |
p. 516-524
9 p.
|
artikel
|
| 23 |
New agency to tackle cancer in Indigenous Australians
|
Kirby, Tony
|
|
2013
|
14 |
6 |
p. 458-
1 p.
|
artikel
|
| 24 |
New immune therapy shows success against B-cell ALL
|
Davies, Rachael
|
|
2013
|
14 |
6 |
p. e202-
1 p.
|
artikel
|
| 25 |
New options for second-line therapy of advanced renal cancer
|
Bex, Axel
|
|
2013
|
14 |
6 |
p. 450-451
2 p.
|
artikel
|
| 26 |
Non-invasive ventilation for end-of-life oncology patients
|
Azoulay, Elie
|
|
2013
|
14 |
6 |
p. e200-e201
nvt p.
|
artikel
|
| 27 |
Non-invasive ventilation for end-of-life oncology patients
|
Azad, Arun
|
|
2013
|
14 |
6 |
p. e199-e200
nvt p.
|
artikel
|
| 28 |
Non-invasive ventilation for end-of-life oncology patients – Authors' reply
|
Nava, Stefano
|
|
2013
|
14 |
6 |
p. e201-
1 p.
|
artikel
|
| 29 |
Patients would benefit from simplified ethical review and consent procedure
|
Hansson, Mats G
|
|
2013
|
14 |
6 |
p. 451-453
3 p.
|
artikel
|
| 30 |
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
|
Swain, Sandra M
|
|
2013
|
14 |
6 |
p. 461-471
11 p.
|
artikel
|
| 31 |
Protein phosphatase 2A: a target for anticancer therapy
|
Perrotti, Danilo
|
|
2013
|
14 |
6 |
p. e229-e238
nvt p.
|
artikel
|
| 32 |
Radiation-free treatment for some lymphoma subtypes?
|
Sharma, Sharan Prakash
|
|
2013
|
14 |
6 |
p. e204-
1 p.
|
artikel
|
| 33 |
Radiotherapy capacity in Europe
|
Charalambous, Haris
|
|
2013
|
14 |
6 |
p. e196-
1 p.
|
artikel
|
| 34 |
Radiotherapy capacity in Europe
|
Grau, Cai
|
|
2013
|
14 |
6 |
p. e196-e198
nvt p.
|
artikel
|
| 35 |
Radiotherapy capacity in Europe – Authors' reply
|
Rosenblatt, Eduardo
|
|
2013
|
14 |
6 |
p. e198-e199
nvt p.
|
artikel
|
| 36 |
Regulating clinical trials in Europe
|
Willmott, Glenis
|
|
2013
|
14 |
6 |
p. 453-454
2 p.
|
artikel
|
| 37 |
Relapsed childhood acute lymphoblastic leukaemia
|
Bhojwani, Deepa
|
|
2013
|
14 |
6 |
p. e205-e217
nvt p.
|
artikel
|
| 38 |
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
|
Mossé, Yael P
|
|
2013
|
14 |
6 |
p. 472-480
9 p.
|
artikel
|
| 39 |
Targeted therapy for gastric cancer
|
Fujita, Tetsuji
|
|
2013
|
14 |
6 |
p. 440-442
3 p.
|
artikel
|
| 40 |
Targeted treatments for breast cancer: a step forward
|
Bachelot, Thomas
|
|
2013
|
14 |
6 |
p. 438-439
2 p.
|
artikel
|
| 41 |
TERT hypermethylation: biomarker in paediatric brain tumours
|
Diede, Scott J
|
|
2013
|
14 |
6 |
p. 447-448
2 p.
|
artikel
|
| 42 |
Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study
|
Buikhuisen, Wieneke A
|
|
2013
|
14 |
6 |
p. 543-551
9 p.
|
artikel
|
| 43 |
The need for proportionate regulation of clinical trials
|
Kearns, Pamela
|
|
2013
|
14 |
6 |
p. 454-455
2 p.
|
artikel
|
| 44 |
Timing of hormone therapy for prostate cancer
|
Baker, Holly
|
|
2013
|
14 |
6 |
p. e203-
1 p.
|
artikel
|
Tijdschrift beschrijving